Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy

Citation
T. Bordet et al., Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy, J CLIN INV, 104(8), 1999, pp. 1077-1085
Citations number
53
Categorie Soggetti
Medical Research General Topics
Journal title
JOURNAL OF CLINICAL INVESTIGATION
ISSN journal
00219738 → ACNP
Volume
104
Issue
8
Year of publication
1999
Pages
1077 - 1085
Database
ISI
SICI code
0021-9738(199910)104:8<1077:ACGTPP>2.0.ZU;2-S
Abstract
Cardiotrophin-1 (CT-1), an IL-6-related cytokine, causes hypertrophy of car diac myocytes and has pleiotropic effects on various other cell types, incl uding motoneurons. Here, we analyzed systemic CT-1 effects in progressive m otor neuronopathy (pmn) mice that suffer from progressive motoneuronal dege neration, muscle paralysis, and premature death. Administration of an adeno viral CT-1 vector to newborn pmn mice leads to sustained CT-1 expression in the injected muscles and bloodstream, prolonged survival of animals, and i mproved motor functions. CT-1-treated pmn mice showed a significantly reduc ed degeneration of facial motoneuron cytons and phrenic nerve myelinated ax ons. The terminal innervation of skeletal muscle, grossly disturbed in untr eated pmn mice, was almost completely preserved in CT-1-treated pmn mice. T he remarkable neuroprotection conferred by CT-1 might become clinically rel evant if CT-1 side effects, including cardiotoxicity, could be circumvented by a more targeted delivery of this cytokine to the nervous system.